2m 2m 2m 2m 2m 2m 2m
SOLID BSCNCS (SLDB)
NASDAQ
$6.81+$0.23 (+3.56%)
Price as of Jun 03, 2026 5:52 PM EDT- $722.6MMarket Cap
- 88.00%1-Year Change
- BiotechnologyIndustry
SOLID BSCNCS (SLDB)
$6.81+$0.23 (+3.56%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 0 -100.00% | 8.1M -40.57% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 2.0M N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 6.1M -55.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -140.3M +45.52% | -96.4M +25.95% | -76.6M -2.37% | -78.4M +33.51% | |
Depreciation and Amortization Expense | 1.6M -33.36% | 2.5M -4.88% | 2.6M +7.18% | 2.4M -18.76% | |
Total Operating Expenses | 179.2M +38.14% | 129.7M +24.44% | 104.3M -8.99% | 114.5M +33.39% | |
Operating Profit | -179.2M +38.14% | -129.7M +24.44% | -104.3M -2.07% | -106.5M +47.33% | |
Interest Income | 9.9M +4.59% | 9.5M +32.58% | 7.1M +173.01% | 2.6M +3,987.50% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 9.9M +4.59% | 9.5M +32.58% | 7.1M +173.01% | 2.6M +3,987.50% | |
Total Nonoperating Income and Expense | 4.9M -2.98% | 5.0M -38.92% | 8.2M -59.76% | 20.5M +30,916.67% | |
Income before Taxes | -179.2M +38.14% | -129.7M +24.44% | -104.3M -2.07% | -106.5M +47.33% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -174.3M +39.80% | -124.7M +29.87% | -96.0M +11.67% | -86.0M +19.11% | |
Net Income from Continuing Operations Applicable to Common | -174.3M +39.80% | -124.7M +29.87% | -96.0M +11.67% | -86.0M +19.11% | |
Basic EPS and Net Income | -1.99 -34.97% | -3.06 -36.65% | -4.83 -52.18% | -10.10 +1,385.29% | |
Diluted EPS and Net Income | -1.99 -34.97% | -3.06 -36.65% | -4.83 -52.18% | -10.10 +1,385.29% | |
Basic Weighted Average Shares | 87.5M +114.38% | 40.8M +105.27% | 19.9M +133.60% | 8.5M -92.03% | |
Diluted Weighted Average Shares | 87.5M +114.38% | 40.8M +105.27% | 19.9M +133.60% | 8.5M -92.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 59.9M -25.34% | 80.2M +8.40% | 74.0M -52.37% | 155.4M +30.43% | |
Short-Term Investments | 128.0M +86.29% | 68.7M +38.41% | 49.6M -14.94% | 58.3M -34.19% | |
Cash and Cash Equivalents and Short-Term Investments | 187.8M +26.14% | 148.9M +20.45% | 123.6M -42.15% | 213.7M +2.86% | |
Total Current Assets | 205.5M +30.61% | 157.3M +21.25% | 129.7M -40.93% | 219.6M -1.34% | |
Accumulated Depreciation | 14.2M +8.94% | 13.0M +2.29% | 12.7M +16.24% | 11.0M -6.05% | |
Property and Plant and Equipment and Net | 4.2M -12.18% | 4.7M -28.34% | 6.6M -31.41% | 9.7M +49.44% | |
Total Long-Term Assets | 27.1M -13.64% | 31.4M +14,904.78% | 209,000 +19.43% | 175,000 +86.17% | |
Total Assets | 232.5M +23.26% | 188.7M +14.38% | 164.9M -36.62% | 260.3M +11.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 33.5M +10.63% | 30.3M +108.42% | 14.5M -35.50% | 22.5M -4.63% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 19.1M -9.93% | 21.2M +21,940.63% | 96,000 0.00% | 96,000 -92.62% | |
Total Liabilities | 52.5M +2.17% | 51.4M +33.69% | 38.5M -20.85% | 48.6M +101.03% | |
Retained Earnings | -957.8M +22.25% | -783.5M +18.93% | -658.8M +17.06% | -562.7M +18.03% | |
Total Stockholders Equity | 180.0M +31.16% | 137.2M +8.51% | 126.5M -40.25% | 211.7M +1.66% | |
Total Shares Outstanding | 79.0M +95.14% | 40.5M +98.50% | 20.4M +4.24% | 19.6M -82.28% | |
Cash Flow | |||||
Cash from Operating Activities | -156.3M +56.27% | -100.0M +6.19% | -94.2M -3.88% | -98.0M +25.99% | |
Capital Expenditures | 1.2M +76.30% | 654,000 -56.83% | 1.5M -49.75% | 3.0M +135.36% | |
Cash from Investing Activities | -58.5M +263.38% | -16.1M -266.02% | 9.7M -83.62% | 59.2M +164.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 194.4M +58.81% | 122.4M +3,821.75% | 3.1M -95.83% | 74.8M -44.56% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 75.72% N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -1,315.20% +147.92% | |
Return on Assets | -82.77% +17.36% | -70.53% +56.17% | -45.16% +29.38% | -34.91% -2.43% | |
Return on Equity | -109.90% +16.21% | -94.57% +66.52% | -56.79% +38.66% | -40.96% -3.47% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% +146.47% | -40.57% N/A | |
Current Ratio | 6.14 +18.07% | 5.20 -41.83% | 8.94 -8.42% | 9.76 +3.46% | |
Cash Ratio | 1.79 -32.51% | 2.65 -47.99% | 5.10 -26.15% | 6.90 +36.76% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow